J Korean Med Sci.  2010 Oct;25(10):1467-1472. 10.3346/jkms.2010.25.10.1467.

Alternative Energy Sources for Surgical Treatment of Atrial Fibrillation in Patients Undergoing Mitral Valve Surgery: Microwave Ablation vs Cryoablation

Affiliations
  • 1Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. jwlee@amc.seoul.kr

Abstract

The study aim was to compare maze outcomes using microwave ablation or cryoablation in patients with mitral disease and atrial fibrillation (AF). Between 1999 and 2005, 340 patients underwent mitral valve surgery and concomitant maze procedure involving either microwave ablation (n=96, MW group) or cryoablation (n=244, Cryo group). Mean age at operation was 50.0+/-12.5 yr. Follow-up period was 46.1+/-28.2 months. The Cryo group showed a longer aortic clamping time than the MW group (P=0.005). There were no differences in operative mortality and morbidity rates. The unadjusted 5-yr AF free rate was 61.3+/-1.2% in the MW group and 79.9+/-3.2% in the Cryo group (P=0.089). After adjustment, the MW group only showed a tendency toward more frequent AF recurrence than the Cryo group (Hazard ration 1.66, 95% confidence interval 0.89 to 3.07). Multivariate analysis revealed that older patient age (P<0.001) and greater left atrial size (P<0.001) were independent risk factors for AF recurrence. Although the use of microwave ablation results in shorter aortic clamping time, it has a tendency toward more frequent late AF recurrence than with cryoablation.

Keyword

Atrial Fibrillation; Mitral Valve; Ablation Therapy; Surgery

MeSH Terms

Adult
Aged
Atrial Fibrillation/mortality/*surgery/therapy
*Cryosurgery
Disease-Free Survival
Female
Follow-Up Studies
Humans
Male
*Microwaves
Middle Aged
Mitral Valve/*surgery

Figure

  • Fig. 1 Freedom from AF without administration of antiarrhythmic agents. In the Cryo group, the AF-free rates were 87.8%±2.2% at 3 yr and 79.9%±3.2% at 5 yr. In the MW group, the AF-free rates were 79.9%±4.9% at 3 yr and 61.3%±1.2% at 5 yr (P=0.089). AF, atrial fibrillation.

  • Fig. 2 Transmitral A-wave prevalence (%). Inter-group comparisons of A-wave prevalence show no differences during the postoperative period (P values ranged from 0.18 to 1.0 for each postoperative point).

  • Fig. 3 Transmitral peak A-wave velocity (cm/sec). Inter-group comparisons of A-wave velocity show no differences during the postoperative period (P values ranged from 0.16 to 0.84 for each postoperative point).


Reference

1. Cox JL, Boineau JP, Schuessler RB, Kater KM, Lappas DG. Five-year experience with the maze procedure for atrial fibrillation. Ann Thorac Surg. 1993. 56:814–823.
Article
2. Cox JL, Schuessler RB, Lappas DG, Boineau JP. An 8 1/2-year clinical experience with surgery for atrial fibrillation. Ann Surg. 1996. 224:267–273.
3. Chiappini B, Di Bartolomeo R, Marinelli G. The surgical treatment of atrial fibrillation with microwave ablation: preliminary experience and results. Interact Cardiovasc Thorac Surg. 2003. 2:327–330.
Article
4. Knaut M, Spitzer SG, Karolyi L, Ebert HH, Richter P, Tugtekin SM, Schuler S. Intraoperative microwave ablation for curative treatment of atrial fibrillation in open heart surgery--the MICRO-STAF and MICRO-PASS pilot trial. MICROwave Application in Surgical treatment of Atrial Fibrillation. MICROwave Application for the Treatment of Atrial Fibrillation in Bypass-Surgery. Thorac Cardiovasc Surg. 1999. 47:Suppl 3. 379–384.
5. Melo J, Adragao P, Neves J, Ferreira MM, Pinto MM, Rebocho MJ, Parreira L, Ramos T. Surgery for atrial fibrillation using radiofrequency catheter ablation: assessment of results at one year. Eur J Cardiothorac Surg. 1999. 15:851–854.
Article
6. Comas GM, Imren Y, Williams MR. An overview of energy sources in clinical use for the ablation of atrial fibrillation. Semin Thorac Cardiovasc Surg. 2007. 19:16–24.
Article
7. Knaut M, Tugtekin SM, Spitzer SG, Jung F, Matschke K. Intraoperative endocardial microwave ablation for treatment of permanent atrial fibrillation during coronary artery bypass surgery: 1-year follow-up. Europace. 2006. 8:16–20.
Article
8. Topkara VK, Williams MR, Barili F, Bastos R, Liu JF, Liberman EA, Russo MJ, Oz MC, Argenziano M. Radiofrequency and microwave energy sources in surgical ablation of atrial fibrillation: a comparative analysis. Heart Surg Forum. 2006. 9:E614–E617.
Article
9. Wisser W, Khazen C, Deviatko E, Stix G, Binder T, Seitelberger R, Schmidinger H, Wolner E. Microwave and radiofrequency ablation yield similar success rates for treatment of chronic atrial fibrillation. Eur J Cardiothorac Surg. 2004. 25:1011–1017.
10. European Heart Rhythm Association (EHRA). European Cardiac Arrhythmia Scoiety (ECAS). American College of Cardiology (ACC). American Heart Association (AHA). Society of Thoracic Surgeons (STS). Calkins H, Brugada J, Packer DL, Cappato R, Chen SA, Crijns HJ, Damiano RJ Jr, Davies DW, Haines DE, Haissaguerre M, Iesaka Y, Jackman W, Jais P, Kottkamp H, Kuck KH, Lindsay BD, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Natale A, Pappone C, Prystowsky E, Raviele A, Ruskin JN, Shemin RJ. HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2007. 4:816–861.
11. Kim JB, Lee SH, Jung SH, Yun SC, Choo SJ, Chung CH, Song H, Lee JW. The influence of postoperative mitral valve function on the late recurrence of atrial fibrillation after the maze procedure combined with mitral valvuloplasty. J Thorac Cardiovasc Surg. 2010. 139:1170–1176.
Article
12. Lee JW, Choo SJ, Kim KI, Song JK, Kang DH, Song JM, Song H, Lee SK, Song MG. Atrial fibrillation surgery simplified with cryoablation to improve left atrial function. Ann Thorac Surg. 2001. 72:1479–1483.
Article
13. Robins JM, Hernan MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology. 2000. 11:550–560.
Article
14. Normand SL. Evaluating the optimal timing of angiography: landmark or off the mark? Circulation. 2007. 116:2656–2657.
15. Cox JL, Ad N, Palazzo T, Fitzpatrick S, Suyderhoud JP, DeGroot KW, Pirovic EA, Lou HC, Duvall WZ, Kim YD. Current status of the Maze procedure for the treatment of atrial fibrillation. Semin Thorac Cardiovasc Surg. 2000. 12:15–19.
Article
16. Itoh A, Kobayashi J, Bando K, Niwaya K, Tagusari O, Nakajima H, Komori S, Kitamura S. The impact of mitral valve surgery combined with maze procedure. Eur J Cardiothorac Surg. 2006. 29:1030–1035.
Article
17. Bando K, Kobayashi J, Kosakai Y, Hirata M, Sasako Y, Nakatani S, Yagihara T, Kitamura S. Impact of Cox maze procedure on outcome in patients with atrial fibrillation and mitral valve disease. J Thorac Cardiovasc Surg. 2002. 124:575–583.
Article
18. Nakajima H, Kobayashi J, Bando K, Niwaya K, Tagusari O, Sasako Y, Nakatani T, Kitamura S. The effect of cryo-maze procedure on early and intermediate term outcome in mitral valve disease: case matched study. Circulation. 2002. 106:I46–I50.
19. Whayne JG, Nath S, Haines DE. Microwave catheter ablation of myocardium in vitro. Assessment of the characteristics of tissue heating and injury. Circulation. 1994. 89:2390–2395.
Article
20. Vicol C, Kellerer D, Petrakopoulou P, Kaczmarek I, Lamm P, Reichart B. Long-term results after ablation for long-standing atrial fibrillation concomitant to surgery for organic heart disease: is microwave energy reliable? J Thorac Cardiovasc Surg. 2008. 136:1156–1159.
Article
21. Accord RE, van Suylen RJ, van Brakel TJ, Maessen JG. Post-mortem histologic evaluation of microwave lesions after epicardial pulmonary vein isolation for atrial fibrillation. Ann Thorac Surg. 2005. 80:881–887.
Article
22. Gillinov AM, Blackstone EH, McCarthy PM. Atrial fibrillation: current surgical options and their assessment. Ann Thorac Surg. 2002. 74:2210–2217.
Article
23. Schuetz A, Schulze CJ, Sarvanakis KK, Mair H, Plazer H, Kilger E, Reichart B, Wildhirt SM. Surgical treatment of permanent atrial fibrillation using microwave energy ablation: a prospective randomized clinical trial. Eur J Cardiothorac Surg. 2003. 24:475–480.
Article
24. Venturini A, Polesel E, Cutaia V, Asta A, Mangino D, Moretti R, Terrini A, Zussa C. Intraoperative microwave ablation in patients undergoing valvular surgery: midterm results. Heart Surg Forum. 2003. 6:409–411.
25. Williams MR, Argenziano M, Oz MC. Microwave ablation for surgical treatment of atrial fibrillation. Semin Thorac Cardiovasc Surg. 2002. 14:232–237.
Article
Full Text Links
  • JKMS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr